Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer
Authors
Keywords
-
Journal
JAMA Surgery
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-07-20
DOI
10.1001/jamasurg.2022.2749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy
- (2021) Yosuke Kano et al. EJSO
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matching
- (2021) Ze-Ning Huang et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Surgeon Quality Control and Standardization of D2 Lymphadenectomy for Gastric Cancer
- (2020) Sang-Uk Han et al. ANNALS OF SURGERY
- Mechanisms of adhesive small bowel obstruction and outcome of surgery; a population-based study
- (2020) Thorbjörn Sakari et al. BMC Surgery
- Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies
- (2020) Xin Chen et al. EJSO
- Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial
- (2020) Woo Jin Hyung et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer
- (2019) Hyung-Ho Kim et al. JAMA Oncology
- Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
- (2019) Everardo D Saad et al. LANCET ONCOLOGY
- Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
- (2019) Ryo Takahashi et al. Gastric Cancer
- Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT)
- (2019) Hyuk-Joon Lee et al. ANNALS OF SURGERY
- Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer
- (2019) Jiang Yu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of an antiadhesive agent for the prevention of intra-abdominal adhesions after radical gastrectomy
- (2019) Sung Geun Kim et al. MEDICINE
- Well-designed retrospective study versus small-sample prospective study in research based on laparoscopic and open radical distal gastrectomy for advanced gastric cancer
- (2019) Jia-Bin Wang et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer
- (2018) Young Kyu Park et al. ANNALS OF SURGERY
- Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer
- (2018) Takahiro Kinoshita et al. ANNALS OF SURGERY
- Postoperative mechanical small bowel obstruction induced by V-Loc barbed absorbable suture after laparoscopic distal gastrectomy
- (2017) Sung Ho Jang et al. Annals of Surgical Treatment and Research
- Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial
- (2015) Hoon Hur et al. BMC CANCER
- Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients
- (2015) Hyung Suk Kim et al. Frontiers in Oncology
- Discrepancy Between Recurrence-Free Survival and Overall Survival in Patients with Resectable Colorectal Liver Metastases: A Potential Surrogate Endpoint for Time to Surgical Failure
- (2014) Masaru Oba et al. ANNALS OF SURGICAL ONCOLOGY
- Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893]
- (2014) Hyoung-Il Kim et al. BMC CANCER
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
- (2013) Koji Oba et al. JNCI-Journal of the National Cancer Institute
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Complications Requiring Reoperation after Gastrectomy for Gastric Cancer: 17 Years Experience in a Single Institute
- (2008) Sung Jin Oh et al. JOURNAL OF GASTROINTESTINAL SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More